ERBB2 and breast cancer: Apart from mBC, TK1 activity results of the NeoPalAna, enrolling ER+/HER2- early BC patients to receive four weeks of anastrozole followed by four cycles of palbociclib plus anastrozole before surgery, are worth to mention20.